CA Patent

CA2044511A1 — Pharmaceutical resorption-improved somatostatin compositions, their preparation and use

Assigned to Novartis AG · Expires 1991-12-16 · 34y expired

What this patent protects

ABSTRACT Pharmaceutical compositions and pharmaceutical administration comprising a somatostatin and cheno- or/and ursodeoxycholic acid, the components combined in a manner admitting their transmucosal administration via the same route.

USPTO Abstract

ABSTRACT Pharmaceutical compositions and pharmaceutical administration comprising a somatostatin and cheno- or/and ursodeoxycholic acid, the components combined in a manner admitting their transmucosal administration via the same route.

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: CA2044511A1
Jurisdiction: CA
Classification: —
Expires: 1991-12-16
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.